Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Abbott Medical - VERITAS Study

NCT: NCT06707688 · ACTIVE_NOT_RECRUITING

NCT IDNCT06707688
StatusACTIVE_NOT_RECRUITING
Start Date2024-11-07
Completion2027-09
SponsorAbbott Medical Devices (INDUSTRY)
First posted
Last updated

Brief Summary

The primary objective of this study is to evaluate the safety and effectiveness of Abbott's Amulet™ 2 Left Atrial Appendage (LAA) occluder device (Amulet 2 device) in patients who have non-valvular atrial fibrillation and who are at increased risk for stroke and systemic embolism and have appropriate rationale to seek a non-pharmacologic alternative to oral anticoagulation.

Frequently Asked Questions

What is Abbott Medical - VERITAS Study?

Abbott Medical - VERITAS Study is a clinical trial registered under NCT06707688. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT06707688?

The current status of NCT06707688 (Abbott Medical - VERITAS Study) is: ACTIVE_NOT_RECRUITING.

When did Abbott Medical - VERITAS Study start?

Abbott Medical - VERITAS Study started on 2024-11-07.

Related Devices

PMA P200049System, appendage closure, left atrialABBOTT MEDICAL PMA P220013Catheter, percutaneous, cardiac ablation, for treatment of atrial fibrillationABBOTT MEDICAL PMA P250022Percutaneous Cardiac Ablation Catheter for Treatment of Atrial Fibrillation with Irreversible ElectroporationABBOTT MEDICAL

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑